Medical Countermeasures | Page 2 of 83 | Global Biodefense

Menu

More stories

in Antimicrobial Resistance, Medical Countermeasures

Antibiotic Resistance Could Take Us Back To the ‘Dark Ages’

by Global Biodefense November 6, 2018, 2:22 pm
in Featured, Medical Countermeasures, Research

Multidomain Antibody to Neutralize Flu Virus Through Entire Season

by Global Biodefense November 6, 2018, 7:40 am
in CBRNE, Featured, Medical Countermeasures

Seizure Drug Approval Expands Countermeasures for Chemical Weapons Attack
in Featured, Medical Countermeasures, Research

Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker

by Global Biodefense October 29, 2018, 9:33 am
in Medical Countermeasures

SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

by Global Biodefense October 4, 2018, 3:30 am
in Antimicrobial Resistance, Medical Countermeasures, Pathogens, Research

Focus on Melioidosis: Highlighted News and Research

by Stephanie Lizotte September 21, 2018, 6:34 am
in Funding, Medical Countermeasures

Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding

by Global Biodefense September 20, 2018, 9:30 am
in Medical Countermeasures, Pathogens

A Review of Ebola Vaccine Candidates
in Featured, Medical Countermeasures

First Human Trial of Live, Attenuated Zika Vaccine Begins

by Global Biodefense August 16, 2018, 10:36 am
in Medical Countermeasures

CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine

by Global Biodefense August 12, 2018, 3:36 pm
in Antimicrobial Resistance, Funding, Medical Countermeasures

Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994

by Global Biodefense July 16, 2018, 5:28 am
in Medical Countermeasures, Pathogens

Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine

by Global Biodefense July 12, 2018, 11:28 am

Congratulations. You've reached the end of the internet.

Close Add post

close